Diabetes-induced early molecular and functional changes in aortic heart valves in a murine model of atherosclerosis.
Animals
Aortic Valve
/ metabolism
Atherosclerosis
/ complications
Blood Glucose
/ metabolism
Cell Adhesion Molecules
/ metabolism
Diabetes Mellitus, Experimental
/ complications
Diabetes Mellitus, Type 1
/ complications
Extracellular Matrix
/ metabolism
Glycated Hemoglobin
/ metabolism
Heart Valve Diseases
/ etiology
Hemodynamics
Inflammation Mediators
/ metabolism
Lipids
/ blood
Male
Mice, Knockout, ApoE
Osteogenesis
Time Factors
Diabetes
aortic valve
cardiovascular aortic valve disease
extracellular matrix remodelling
inflammatory markers
osteogenic markers
Journal
Diabetes & vascular disease research
ISSN: 1752-8984
Titre abrégé: Diab Vasc Dis Res
Pays: England
ID NLM: 101234011
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
pubmed:
19
9
2019
medline:
20
2
2020
entrez:
19
9
2019
Statut:
ppublish
Résumé
Diabetes contributes directly to the development of cardiovascular aortic valve disease. There is currently no drug therapy available for a dysfunctional valve and this urges the need for additional research to identify distinctive mechanisms of cardiovascular aortic valve disease evolution. The aim of this study was to evaluate changes of valvular aortic lesions induced in a hyperlipemic ApoE
Identifiants
pubmed: 31530180
doi: 10.1177/1479164119874469
pmc: PMC6787765
doi:
Substances chimiques
Blood Glucose
0
Cell Adhesion Molecules
0
Glycated Hemoglobin A
0
HbA(1c) protein, mouse
0
Inflammation Mediators
0
Lipids
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
562-576Références
Int J Inflam. 2011;2011:364310
pubmed: 21826258
Hepatology. 2013 Jan;57(1):81-92
pubmed: 22508243
J Am Coll Cardiol. 2015 Aug 4;66(5):561-77
pubmed: 26227196
Diabetes. 2008 Oct;57(10):2762-7
pubmed: 18633113
J Inflamm (Lond). 2013 Oct 09;10(1):32
pubmed: 24107300
J Thorac Cardiovasc Surg. 2009 Oct;138(4):1008-15
pubmed: 19664780
Clin Biochem. 2004 Dec;37(12):1091-7
pubmed: 15589815
Diab Vasc Dis Res. 2019 May;16(3):254-269
pubmed: 30563371
Am J Physiol Endocrinol Metab. 2003 Jun;284(6):E1089-97
pubmed: 12582013
Science. 1976 Jul 30;193(4251):415-7
pubmed: 180605
J Am Coll Cardiol. 2006 Feb 21;47(4):850-5
pubmed: 16487855
Recent Pat Endocr Metab Immune Drug Discov. 2011 May;5(2):124-46
pubmed: 22074587
Clin Endocrinol (Oxf). 2011 Oct;75(4):450-5
pubmed: 21521338
Circulation. 2001 Mar 20;103(11):1522-8
pubmed: 11257079
J Bone Miner Res. 2003 Mar;18(3):493-501
pubmed: 12619934
J Am Coll Cardiol. 2017 Mar 28;69(12):1523-1532
pubmed: 28335833
J Clin Invest. 1997 Mar 1;99(5):1037-43
pubmed: 9062362
Am J Pathol. 1996 Mar;148(3):997-1014
pubmed: 8774154
Clin Biochem Rev. 2004 Feb;25(1):81-93
pubmed: 18516202
World J Diabetes. 2015 Oct 10;6(13):1246-58
pubmed: 26468341
Arterioscler Thromb Vasc Biol. 2014 Oct;34(10):2283-91
pubmed: 25231636
Arterioscler Thromb Vasc Biol. 2016 Jul;36(7):1398-405
pubmed: 27199449
Ann Thorac Surg. 2007 Mar;83(3):946-53
pubmed: 17307438
Circulation. 2011 Oct 18;124(16):1783-91
pubmed: 22007101
BMC Cardiovasc Disord. 2014 Mar 01;14:29
pubmed: 24581344
J Mol Med (Berl). 2015 Apr;93(4):403-12
pubmed: 25412776
PLoS One. 2013 Dec 23;8(12):e84433
pubmed: 24376809
Circulation. 2003 May 6;107(17):2181-4
pubmed: 12719282
Sci Rep. 2016 Sep 13;6:32659
pubmed: 27619752
Circ Res. 1999 Jun 11;84(11):1237-44
pubmed: 10364560
Circulation. 2007 Dec 11;116(24):2841-50
pubmed: 18040026
J Cardiovasc Pharmacol. 2015 Jul;66(1):63-71
pubmed: 25806689